(1)

Regulation (EC) No 1831/2003 provides for the authorisation of additives for use in animal nutrition and for the grounds and procedures for granting such an authorisation.

(2)

In accordance with Article 7 of Regulation (EC) No 1831/2003, two applications were submitted, one for the authorisation of a preparation of Limosilactobacillus reuteri DSM 32203 and one for the authorisation of a preparation of Limosilactobacillus reuteri DSM 32264. Those applications were accompanied by the particulars and documents required under Article 7(3) of Regulation (EC) No 1831/2003.

(3)

The applications concern the authorisation of the preparation of Limosilactobacillus reuteri DSM 32203 as a feed additive for dogs and the preparation of Limosilactobacillus reuteri DSM 32264 as a feed additive for cats, to be classified in the category ‘zootechnical additives’ and in the functional group ‘gut flora stabilisers’.

(4)

The European Food Safety Authority (‘the Authority’) concluded in its opinions of 27 November 2018 (2) , (3) and of 29 June 2022 (4) , (5) that, under the proposed conditions of use, the preparations of Limosilactobacillus reuteri DSM 32203 and of Limosilactobacillus reuteri DSM 32264 do not have adverse effects on animal health, consumer safety or the environment. It also concluded that those preparations should be considered a potential respiratory sensitiser, and that in the absence of data, it could not conclude on the irritancy potential of the additives to skin and eyes or on its dermal sensitisation potential. The Authority also concluded that the preparations of Limosilactobacillus reuteri DSM 32203 and of Limosilactobacillus reuteri DSM 32264 have the potential to be efficacious in improving the faecal consistency. However, the Authority expressed some reservations on linear decrease in the moisture content of faeces, which if maintained over time, might cast doubts on the benefits on the long-term use of the additives since it could lead to constipation. It also verified the report on the methods of analysis of the feed additives in feed submitted by the Reference Laboratory set up by Regulation (EC) No 1831/2003.

(5)

The assessment of the preparations of Limosilactobacillus reuteri DSM 32203 and of Limosilactobacillus reuteri DSM 32264 shows that the conditions for authorisation, as provided for in Article 5 of Regulation (EC) No 1831/2003, are satisfied. Accordingly, the use of those preparations should be authorised. It is appropriate to provide for post-market monitoring and for specific labelling of the additives and premixtures containing them as regards possible long-term adverse effects of the use of the additives. In addition, the Commission considers that appropriate protective measures should be taken to prevent adverse effects on human health, in particular as regards the users of the additives.

(6)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,